Medicine and Dentistry
Surgery
100%
Crohn's Disease
85%
Recurrent Disease
64%
Immunomodulating Agent
23%
Risk Stratification
22%
Bowel Resection
22%
Postoperative Management
22%
Patient with Crohn's Disease
21%
Diseases
19%
Cohort Analysis
18%
Prophylaxis
16%
Tumor Necrosis Factor
16%
Cohort Effect
16%
Retreatment
16%
Prospective Study
16%
Monotherapy
16%
Hazard Ratio
13%
Combination Therapy
9%
Biological Product
7%
Proportional Hazards Model
6%
Inflammatory Bowel Disease
6%
TNF Inhibitor
6%
4-Aminosalicylic Acid
5%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
66%
Recurrent Disease
60%
Tumor Necrosis Factor
33%
Diseases
25%
Immunomodulating Agent
23%
Prospective Study
16%
Monotherapy
16%
Mercaptopurine
16%
Tumor Necrosis Factor Inhibitor
12%
Biological Product
8%
Combination Therapy
7%
Aminosalicylic Acid
6%
Recurrence Risk
5%